REG - CVS Group plc - Transaction in Own Shares
Yesterday 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251210:nRSJ9034Ka&default-theme=true
RNS Number : 9034K CVS Group plc 10 December 2025
10 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 09 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 09/12/2025
Aggregate number of Ordinary Shares purchased: 20,428
Lowest price paid per share (GBp): 1,202.00
Highest price paid per share (GBp): 1,230.00
Volume weighted average price paid per share (GBp): 1,222.04
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,915,717 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,915,717 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 825,066 Ordinary Shares in aggregate at a weighted average price
of 1,215.43 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
55 1202 09/12/2025 08:00:51 1348371239405464 XLON
251 1202 09/12/2025 08:00:51 1348371239405465 XLON
577 1210 09/12/2025 08:17:38 1348371239407286 XLON
210 1210 09/12/2025 08:17:38 1348371239407287 XLON
344 1210 09/12/2025 08:17:38 1348371239407288 XLON
307 1208 09/12/2025 08:28:01 1348371239408163 XLON
72 1210 09/12/2025 08:49:59 1348371239409804 XLON
149 1206 09/12/2025 09:00:16 1348371239410809 XLON
454 1216 09/12/2025 09:40:27 1348371239413928 XLON
299 1216 09/12/2025 09:40:27 1348371239413931 XLON
468 1220 09/12/2025 10:23:47 1348371239416807 XLON
464 1220 09/12/2025 10:50:19 1348371239418891 XLON
449 1222 09/12/2025 11:10:11 1348371239420433 XLON
357 1218 09/12/2025 11:11:17 1348371239420573 XLON
92 1218 09/12/2025 11:11:17 1348371239420574 XLON
72 1216 09/12/2025 11:25:24 1348371239421828 XLON
317 1220 09/12/2025 12:11:08 1348371239424968 XLON
101 1220 09/12/2025 12:11:08 1348371239424970 XLON
73 1224 09/12/2025 12:54:50 1348371239427872 XLON
164 1226 09/12/2025 13:01:49 1348371239428316 XLON
141 1226 09/12/2025 13:01:49 1348371239428318 XLON
200 1226 09/12/2025 13:01:49 1348371239428317 XLON
141 1226 09/12/2025 13:01:49 1348371239428339 XLON
294 1226 09/12/2025 13:01:49 1348371239428340 XLON
471 1230 09/12/2025 13:32:07 1348371239430470 XLON
386 1230 09/12/2025 13:32:07 1348371239430471 XLON
79 1228 09/12/2025 13:36:31 1348371239430871 XLON
194 1226 09/12/2025 13:41:55 1348371239431141 XLON
114 1226 09/12/2025 13:41:55 1348371239431142 XLON
194 1226 09/12/2025 13:41:55 1348371239431143 XLON
194 1226 09/12/2025 13:41:55 1348371239431144 XLON
58 1226 09/12/2025 13:41:55 1348371239431145 XLON
136 1226 09/12/2025 13:45:57 1348371239431477 XLON
2132 1226 09/12/2025 13:45:57 1348371239431480 XLON
194 1226 09/12/2025 13:46:55 1348371239431528 XLON
77 1226 09/12/2025 13:46:55 1348371239431529 XLON
35 1226 09/12/2025 13:46:55 1348371239431532 XLON
159 1226 09/12/2025 13:46:55 1348371239431533 XLON
70 1226 09/12/2025 13:46:55 1348371239431534 XLON
194 1226 09/12/2025 13:46:55 1348371239431535 XLON
159 1226 09/12/2025 13:46:55 1348371239431536 XLON
35 1226 09/12/2025 13:46:55 1348371239431537 XLON
159 1226 09/12/2025 13:46:55 1348371239431538 XLON
33 1226 09/12/2025 13:46:55 1348371239431539 XLON
68 1222 09/12/2025 13:46:56 1348371239431545 XLON
41 1222 09/12/2025 13:46:56 1348371239431546 XLON
216 1224 09/12/2025 14:17:47 1348371239434104 XLON
71 1222 09/12/2025 14:21:35 1348371239434424 XLON
71 1222 09/12/2025 14:25:37 1348371239434701 XLON
187 1220 09/12/2025 14:28:11 1348371239434960 XLON
3 1220 09/12/2025 14:28:11 1348371239434961 XLON
78 1220 09/12/2025 14:28:11 1348371239434962 XLON
550 1216 09/12/2025 14:36:09 1348371239436727 XLON
550 1218 09/12/2025 14:37:27 1348371239436869 XLON
340 1218 09/12/2025 14:37:27 1348371239436870 XLON
222 1218 09/12/2025 14:37:27 1348371239436871 XLON
73 1222 09/12/2025 14:50:48 1348371239439225 XLON
71 1224 09/12/2025 15:16:03 1348371239442716 XLON
545 1222 09/12/2025 15:18:49 1348371239443090 XLON
104 1222 09/12/2025 15:18:49 1348371239443091 XLON
5 1222 09/12/2025 15:18:49 1348371239443092 XLON
340 1222 09/12/2025 15:18:49 1348371239443093 XLON
16 1222 09/12/2025 15:29:40 1348371239444662 XLON
30 1222 09/12/2025 15:29:40 1348371239444661 XLON
72 1222 09/12/2025 15:29:40 1348371239444660 XLON
154 1222 09/12/2025 15:29:40 1348371239444659 XLON
100 1222 09/12/2025 15:29:40 1348371239444663 XLON
260 1222 09/12/2025 15:29:40 1348371239444665 XLON
145 1222 09/12/2025 15:29:40 1348371239444664 XLON
194 1222 09/12/2025 15:29:40 1348371239444666 XLON
194 1222 09/12/2025 15:29:40 1348371239444667 XLON
157 1224 09/12/2025 15:37:49 1348371239445810 XLON
377 1226 09/12/2025 15:48:01 1348371239447651 XLON
151 1226 09/12/2025 15:48:01 1348371239447659 XLON
162 1224 09/12/2025 15:49:23 1348371239447831 XLON
46 1224 09/12/2025 15:55:01 1348371239448864 XLON
95 1224 09/12/2025 15:55:01 1348371239448866 XLON
170 1224 09/12/2025 15:55:01 1348371239448865 XLON
68 1224 09/12/2025 15:55:01 1348371239448867 XLON
16 1224 09/12/2025 15:55:01 1348371239448868 XLON
5 1224 09/12/2025 15:55:01 1348371239448869 XLON
5 1224 09/12/2025 15:55:01 1348371239448870 XLON
71 1226 09/12/2025 16:00:22 1348371239449999 XLON
194 1226 09/12/2025 16:03:28 1348371239450693 XLON
10 1226 09/12/2025 16:03:28 1348371239450694 XLON
184 1226 09/12/2025 16:03:28 1348371239450695 XLON
10 1226 09/12/2025 16:03:28 1348371239450696 XLON
184 1226 09/12/2025 16:03:28 1348371239450697 XLON
10 1226 09/12/2025 16:03:28 1348371239450698 XLON
184 1226 09/12/2025 16:03:28 1348371239450699 XLON
194 1226 09/12/2025 16:03:28 1348371239450700 XLON
194 1226 09/12/2025 16:03:28 1348371239450701 XLON
194 1226 09/12/2025 16:03:28 1348371239450702 XLON
194 1226 09/12/2025 16:03:28 1348371239450703 XLON
194 1226 09/12/2025 16:03:28 1348371239450704 XLON
194 1226 09/12/2025 16:03:28 1348371239450705 XLON
194 1226 09/12/2025 16:03:28 1348371239450706 XLON
194 1226 09/12/2025 16:03:28 1348371239450707 XLON
194 1226 09/12/2025 16:03:28 1348371239450708 XLON
194 1226 09/12/2025 16:03:28 1348371239450709 XLON
194 1226 09/12/2025 16:03:28 1348371239450710 XLON
70 1226 09/12/2025 16:03:28 1348371239450711 XLON
29 1226 09/12/2025 16:03:28 1348371239450712 XLON
78 1228 09/12/2025 16:11:59 1348371239452321 XLON
178 1228 09/12/2025 16:19:43 1348371239453830 XLON
16 1228 09/12/2025 16:19:43 1348371239453831 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny Pulbrook
+44 (0)7961
315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSUPGPWPUPAGMB
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Standard form for notification of major holdings
AnnouncementREG - CVS Group plc - Update on move to the Main Market
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
Announcement